Lyra Therapeutics's total assets for Q3 2025 were $43.71M, a decrease of -16.86% from the previous quarter. LYRA total liabilities were $48.04M for the fiscal quarter, a -5.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.